Piramal Pharma Ltd (PPLPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003728, "name": "Piramal Pharma", "stock_name": "Piramal Pharma", "full_name": "Piramal Pharma Ltd", "name_url": "stocks-analysis/piramal-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "141.07", "chg": 4.99, "chgp": "3.67%", "dir": 1, "prev_price": "136.08", "mcapval": "18,789.00 Cr", "mcap": "Small Cap", "scripcode": 543635, "symbol": "PPLPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0DK501011", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "44.54 lacs", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Piramal Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-strong-sell-3909627", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_mojoScore_3909627.png", "date": "2026-03-24 10:10:41", "description": "Piramal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 February 2026, reflecting a shift from the previous 'Sell' grade. However, all fundamentals, returns, and financial metrics discussed here are current as of 24 March 2026, providing an up-to-date view of the stock's position in the market." }, { "title": "Piramal Pharma Ltd Falls to 52-Week Low of Rs 133 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-stock-falls-to-52-week-low-of-rs133-on-23-mar-2026-3908047", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_priceRelatedfactors_3908047.png", "date": "2026-03-23 13:32:38", "description": "A sharp decline of 3.8% on 23 Mar 2026 dragged Piramal Pharma Ltd to a fresh 52-week low of Rs 133, extending a painful downtrend that has seen the stock lose over 41% in the past year, far outpacing the broader market's modest 5.5% decline." }, { "title": "Piramal Pharma Declines 1.21%: 2 Key Factors Behind the Weekly Slide", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-declines-121-2-key-factors-behind-the-weekly-slide-3905080", "imagepath": "", "date": "2026-03-21 11:03:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Mar:</strong> New 52-week low (Rs.134.8)</p>\n <p><strong>18 Mar:</strong> Valuation shifts signal attractive entry amid sector challenges</p>\n <p><strong>20 Mar:</strong> Week closes at Rs.138.25 (-1.21%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.139.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.138.25</div><div class=\"stat-change negative\">-1.21%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." }, { "title": "Piramal Pharma Ltd Valuation Shifts Signal Attractive Entry Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-valuation-shifts-signal-attractive-entry-amid-sector-challenges-3897967", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_valuationdot_3897967.png", "date": "2026-03-18 08:01:15", "description": "Piramal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from fair to attractive territory despite ongoing challenges in its financial performance and stock returns. With a current price of ₹138.55, close to its 52-week low of ₹134.70, the pharmaceutical small-cap’s price-to-earnings (P/E) ratio has plunged to a striking -128.57, signalling significant earnings pressure. This article analyses the evolving valuation landscape of Piramal Pharma in comparison to its sector peers and historical benchmarks, providing a comprehensive view for investors navigating the Pharmaceuticals & Biotechnology space." }, { "title": "Piramal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3893807", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_priceRelatedfactors_3893807.png", "date": "2026-03-16 11:53:07", "description": "Piramal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.134.8 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics." }, { "title": "Piramal Pharma Falls 7.96%: 4 Key Factors Behind the Sharp Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-falls-796-4-key-factors-behind-the-sharp-weekly-decline-3890560", "imagepath": "", "date": "2026-03-14 10:03:39", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 09:</strong> Stock opens at Rs.151.30, down 0.49% as Sensex falls 1.91%</p>\n <p><strong>Mar 10:</strong> Sharp rebound to Rs.155.50 (+2.78%) with Sensex up 1.30%</p>\n <p><strong>Mar 12:</strong> Stock hits 52-week low near Rs.142.95 amid heavy put options activity and 11.9% open interest surge</p>\n <p><strong>Mar 13:</strong> Further decline to new 52-week low Rs.139.95 with 13.7% open interest increase, closing the week down 7.96%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.152.05</div></d..." }, { "title": "Piramal Pharma Ltd Stock Falls to 52-Week Low of Rs.141.4", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-stock-falls-to-52-week-low-of-rs1414-3888812", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_priceRelatedfactors_3888812.png", "date": "2026-03-13 10:15:21", "description": "Piramal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.141.4 on 13 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics." }, { "title": "Piramal Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-strong-sell-3888325", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_mojoScore_3888325.png", "date": "2026-03-13 10:10:43", "description": "Piramal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Feb 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 13 March 2026, providing investors with the latest comprehensive analysis." }, { "title": "Piramal Pharma Sees Sharp Open Interest Surge Amid Bearish Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-sees-sharp-open-interest-surge-amid-bearish-momentum-3888687", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PiramalPharmaLt_oi_spurts_by_underlying_3888687.png", "date": "2026-03-13 10:00:13", "description": "Piramal Pharma Ltd (PPLPHARMA) has witnessed a significant 13.7% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This surge accompanies a fresh 52-week low in the stock price, reflecting growing bearish sentiment amid sustained selling pressure and underperformance relative to its sector and benchmark indices." } ], "total": 407, "sid": "1003728", "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25", "dt": "2025-07-16", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23", "dt": "2023-08-02", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

16 Mar: New 52-week low (Rs.134.8)

18 Mar: Valuation shifts signal attractive entry amid sector challenges

20 Mar: Week closes at Rs.138.25 (-1.21%)

Read full news article

Piramal Pharma Ltd Valuation Shifts Signal Attractive Entry Amid Sector Challenges

2026-03-18 08:01:15

Piramal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from fair to attractive territory despite ongoing challenges in its financial performance and stock returns. With a current price of ₹138.55, close to its 52-week low of ₹134.70, the pharmaceutical small-cap’s price-to-earnings (P/E) ratio has plunged to a striking -128.57, signalling significant earnings pressure. This article analyses the evolving valuation landscape of Piramal Pharma in comparison to its sector peers and historical benchmarks, providing a comprehensive view for investors navigating the Pharmaceuticals & Biotechnology space.

Read full news article

Piramal Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-03-16 11:53:07

Piramal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.134.8 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.

Read full news article

Piramal Pharma Falls 7.96%: 4 Key Factors Behind the Sharp Weekly Decline

2026-03-14 10:03:39

Key Events This Week

Mar 09: Stock opens at Rs.151.30, down 0.49% as Sensex falls 1.91%

Mar 10: Sharp rebound to Rs.155.50 (+2.78%) with Sensex up 1.30%

Mar 12: Stock hits 52-week low near Rs.142.95 amid heavy put options activity and 11.9% open interest surge

Mar 13: Further decline to new 52-week low Rs.139.95 with 13.7% open interest increase, closing the week down 7.96%

Week Open

Rs.152.05

Read full news article

Piramal Pharma Ltd Stock Falls to 52-Week Low of Rs.141.4

2026-03-13 10:15:21

Piramal Pharma Ltd’s shares declined to a fresh 52-week low of Rs.141.4 on 13 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.

Read full news article

Piramal Pharma Ltd is Rated Strong Sell

2026-03-13 10:10:43

Piramal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Feb 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 13 March 2026, providing investors with the latest comprehensive analysis.

Read full news article

Piramal Pharma Sees Sharp Open Interest Surge Amid Bearish Momentum

2026-03-13 10:00:13

Piramal Pharma Ltd (PPLPHARMA) has witnessed a significant 13.7% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This surge accompanies a fresh 52-week low in the stock price, reflecting growing bearish sentiment amid sustained selling pressure and underperformance relative to its sector and benchmark indices.

Read full news article

View All News